Barclays’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7K | Sell |
8,602
-14,543
| -63% | -$11.8K | ﹤0.01% | 4185 |
|
|
2025
Q1 | $18K | Sell |
23,145
-6,628
| -22% | -$5.16K | ﹤0.01% | 4075 |
|
|
2024
Q4 | $38K | Buy |
29,773
+2,608
| +10% | +$3.33K | ﹤0.01% | 4010 |
|
|
2024
Q3 | $57K | Buy |
27,165
+12,564
| +86% | +$26.4K | ﹤0.01% | 3886 |
|
|
2024
Q2 | $56K | Sell |
14,601
-5,786
| -28% | -$22.2K | ﹤0.01% | 3630 |
|
|
2024
Q1 | $97K | Sell |
20,387
-10,139
| -33% | -$48.2K | ﹤0.01% | 3656 |
|
|
2023
Q4 | $131K | Buy |
30,526
+17,210
| +129% | +$73.9K | ﹤0.01% | 3643 |
|
|
2023
Q3 | $42K | Buy |
13,316
+7,264
| +120% | +$22.9K | ﹤0.01% | 3668 |
|
|
2023
Q2 | $27K | Sell |
6,052
-4,270
| -41% | -$19.1K | ﹤0.01% | 3911 |
|
|
2023
Q1 | $59K | Sell |
10,322
-80,502
| -89% | -$460K | ﹤0.01% | 3737 |
|
|
2022
Q4 | $549K | Buy |
90,824
+85,656
| +1,657% | +$518K | ﹤0.01% | 2542 |
|
|
2022
Q3 | $34K | Buy |
5,168
+1,108
| +27% | +$7.29K | ﹤0.01% | 3774 |
|
|
2022
Q2 | $21K | Sell |
4,060
-1,817
| -31% | -$9.4K | ﹤0.01% | 4074 |
|
|
2022
Q1 | $40K | Buy |
+5,877
| New | +$40K | ﹤0.01% | 4088 |
|